4.6 Article

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Georg Semmler et al.

Summary: The study developed risk stratification algorithms for de novo HCC development after SVR in patients with ACLD. Parameters such as post-treatment AFP, alcohol consumption, age, LSM, and albumin accurately predicted de novo HCC development and stratified patients into low- and high-risk groups. These algorithms identified approximately two-thirds of patients with cACLD as having a low risk of <1%/year for HCC development, showing effectiveness in risk assessment and surveillance.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

Dalila Costa et al.

Summary: This study revealed significant differences in liver function, portal hypertension, and systemic inflammation among patients with advanced chronic liver disease at different prognostic stages, with IL-6 levels proving to be predictive of decompensation and mortality risk in decompensated patients.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis

Vicente Arroyo et al.

Summary: Systemic inflammation may be a key feature of acute decompensation of cirrhosis, affecting organ system function through various mechanisms and working synergistically with traditional pathways to contribute to the development of AD. It can exacerbate splanchnic vasodilation by overactivating the endogenous vasoconstrictor systems, leading to hypoperfusion in certain vascular beds such as the renal circulation. Additionally, systemic inflammation may cause immune-mediated tissue damage and induce significant metabolic changes.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Review Gastroenterology & Hepatology

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis

Andrew M. Moon et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Medicine, General & Internal

Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease

Lukas W. Unger et al.

WIENER KLINISCHE WOCHENSCHRIFT (2019)

Article Gastroenterology & Hepatology

Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study

Sumeet K. Asrani et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Review Medicine, General & Internal

Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy

Steven L. Flamm

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)

Review Gastroenterology & Hepatology

Treatment of Dyslipidemia in Common Liver Diseases

Elizabeth K. Speliotes et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013

Sumeet K. Asrani et al.

GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Clinical states of cirrhosis and competing risks

Gennaro D'Amico et al.

JOURNAL OF HEPATOLOGY (2018)

Article Medicine, General & Internal

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

Elliot B Tapper et al.

BMJ-British Medical Journal (2018)

Article Medicine, General & Internal

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

Elliot B Tapper et al.

BMJ-British Medical Journal (2018)

Article Gastroenterology & Hepatology

Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment

Justin Chan et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Article Gastroenterology & Hepatology

Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease

Carolin Lackner et al.

JOURNAL OF HEPATOLOGY (2017)

Article Medicine, General & Internal

Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)

Thomas Reiberger et al.

WIENER KLINISCHE WOCHENSCHRIFT (2017)

Article Gastroenterology & Hepatology

Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis

Jonathan G. Stine et al.

WORLD JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year population-based study

E. Nilsson et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Gastroenterology & Hepatology

Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study

Elliot B. Tapper et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Review Gastroenterology & Hepatology

Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice

Changqing Zhao et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Mattias Mandorfer et al.

JOURNAL OF HEPATOLOGY (2016)

Article Endocrinology & Metabolism

Non-alcoholic fatty liver disease and dyslipidemia: An update

Niki Katsiki et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Gastroenterology & Hepatology

Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis

Jonathan G. Stine et al.

LIVER TRANSPLANTATION (2015)

Article Gastroenterology & Hepatology

Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients

G. D'Amico et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Review Gastroenterology & Hepatology

The burden of liver disease in Europe: A review of available epidemiological data

Martin Blachier et al.

JOURNAL OF HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Prognostic indicators of survival in patients with compensated and decompensated cirrhosis

Alexander Zipprich et al.

LIVER INTERNATIONAL (2012)

Article Gastroenterology & Hepatology

Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study

Peter Jepsen et al.

HEPATOLOGY (2010)

Review Cardiac & Cardiovascular Systems

Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review

Alexey Sorokin et al.

ATHEROSCLEROSIS (2007)

Article Gastroenterology & Hepatology

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis

Cristina Ripoll et al.

GASTROENTEROLOGY (2007)

Review Gastroenterology & Hepatology

The Model for End-stage Liver Disease (MELD)

Patrick S. Kamath et al.

HEPATOLOGY (2007)

Review Gastroenterology & Hepatology

Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

G D'Amico et al.

JOURNAL OF HEPATOLOGY (2006)